The DanGer Shock trial evaluated Impella CP in patients who had a heart attack with cardiogenic shock. At up to 10 years, compared to the standard of care, Impella CP led to an absolute mortality ...

Avasa announced today that it completed the first close of its pre-Series A fundraising round worth about $2.8 million (NZD$4 ...

Intuitive Surgical (Nasdaq: ISRG) notified the state of California of its intention to lay off a total of 331 employees in ...

GE HealthCare CEO Peter Arduini today announced the appointment of Ivan Martinez as the company's new chief strategy officer ...

Envoy Medical (Nasdaq:COCH) announced today that it satisfied and extinguished its outstanding term loans from GAT Funding.

ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...

HeartFocus announced today that it began the U.S. commercial launch for its AI-enabled cardiac imaging software on Butterfly ...

Terumo announced today that it entered into a definitive agreement to acquire OrganOx and its organ preservation technology.

Philips announced today that it launched Transcend Plus, the next generation of its cardiovascular ultrasound offerings.

Henry Schein announced today that it launched LinkIt, a seamless digital workflow for dental practice management.

Ciliatech announced today that it received CE mark approval for its Intercil uveal spacer, an eye implant for treating ...

Abbott announced today that it received CE mark for its Esprit BTK everolimus-eluting resorbable scaffold system.